Life sciences Life sciences Inflamalps takes part in a significant biopharmaceutical research project 16 November 2021
Life sciences The partnership between Lonza and the HES-SO Valais-Wallis is yielding results 31 August 2021
Life sciences Women’s health biopharmaceutical company ObsEva receives USD 500 million 10 August 2021
Life sciences Lonza invests CHF 650 million in a new large-scale production facility in Visp 10 May 2021